Immunization
New immunization research has been reported by scientists at University of Ottawa
Published in Hepatitis Weekly, May 26th, 2008
"Human immunodeficiency virus (HIV)-infected persons are hyporesponsive to hepatitis B virus (HBV) vaccination. CPG 7909 is an oligodeoxynucleotide containing immunostimulatory CpG motifs that activate human B and plasmacytoid dendritic cells via Toll-like receptor 9. We previously reported that addition of CPG 7909 to a commercial HBV vaccine enhanced the kinetics, magnitude, and longevity of the seroprotective response over 48 weeks," scientists in Ottawa, Canada report.
"We now report data for the 5-year period following vaccination. A randomized, double-blind, controlled trial was conducted to determine clinical safety and immunogenicity of HBV vaccine in adult...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-05-26)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Research in the area of acute hepatitis reported from K. Kusumoto and colleagues - Cholangio Cancer
Study results from L.L. Guo and colleagues update understanding of cholangio cancer - Diabetes
Data from D.L. Segev et al provide new insights into diabetes - Enzyme Research
New enzyme research findings from L.V. Jukic and co-researchers published - Hepatitis B Virus
Data from Erasmus University advance knowledge in hepatitis B virus - Hepatitis B Virus
Data on hepatitis B virus published by researchers at Yonsei University, Medical Department - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
